Polvino William James

Polvino William James is listed in filings as Director at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 18, 2025, including 3 public disclosures. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Jul 17, 2024 to Dec 18, 2025. Reported amounts are shown as $40.5K to $598.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.